The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of BAP1 alterations with malignant pleural mesothelioma treated with trimodality therapy.
 
Marjorie Glass Zauderer
Consulting or Advisory Role - Aldeyra Therapeutics; Epizyme
Research Funding - Bristol-Myers Squibb (Inst); Epizyme (Inst); MedImmune (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst)
Other Relationship - Mesothelioma Applied Research Foundation
 
Hira Rizvi
No Relationships to Disclose
 
Mariel A. DuBoff
No Relationships to Disclose
 
Prasad S. Adusumilli
No Relationships to Disclose
 
Valerie W. Rusch
Research Funding - Genelux (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; da Vinci Surgery
Other Relationship - NIH/Coordinating Center for Clinical Trials
 
Jennifer L. Sauter
Stock and Other Ownership Interests - Merck; Thermo Fisher Scientific
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck (I); NCCN/AstraZeneca; Takeda
Research Funding - Helsinn Therapeutics; Loxo (Inst)
 
Andreas Rimner
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Merck; Varian Medical Systems
Research Funding - AstraZeneca; Boehringer Ingelheim; Pfizer; Varian Medical Systems